[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345016-105":59,"doc-detail-345016-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","developments-potential-of-nanotechnology-for-the-detection-and-treatment-of-pancreatic-cancer","Developments - Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer","","Pancreatic cancer is projected to become the second leading cause of cancer death by 2030, driven by delayed diagnosis caused by a lack of clear early symptoms. With only about 20% of cases detected early enough for surgery and a dismal 5-year survival rate (12%), most patients depend on chemotherapy, immunotherapy, and radiotherapy. Chemotherapy can shrink tumors but causes severe side effects. Nanotechnology enables more effective diagnosis and less aggressive therapy, including approved nano-formulations, while numerous nanoparticle approaches remain under active preclinical and clinical investigation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/developments-potential-of-nanotechnology-for-the-detection-and-treatment-of-pancreatic-cancer/345016/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/developments-potential-of-nanotechnology-for-the-detection-and-treatment-of-pancreatic-cancer/345016.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is pancreatic cancer difficult to diagnose early?","Question",{"text":112,"@type":113},"Because clear early symptoms are absent, diagnosis is often delayed, leading many patients to present with advanced disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What treatment options are most commonly used for pancreatic cancer?",{"text":117,"@type":113},"Most patients rely on chemotherapy, immunotherapy, and radiotherapy, since only about 20% of cases are detected early enough for surgery.",{"name":119,"@type":110,"acceptedAnswer":120},"How does nanotechnology aim to improve pancreatic cancer management?",{"text":121,"@type":113},"Nanotechnology supports more effective diagnosis and more efficient therapy, including nano-formulations that can offer improved survival rates and reduced side effects compared with traditional chemotherapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345016,1790367368,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nDevelopments & Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer  \nDanielle O’Meara, Clare Hoskins   \nDepartment of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK  \nCorrespondence: Clare Hoskins, Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow, UK, Email [clare.hoskins@strath.ac.uk](clare.hoskins@strath.ac.uk)  \n\n| Abstract: Pancreatic cancer is projected to become the second leading cause of cancer death by 2030 with a dismal 5-year survival rate compared to other cancers (12%) . Due to the absence of clear early symptoms, diagnosis is often delayed resulting in many patients presenting with advanced disease and limited treatment options. Surgery remains the only potential curative option. However, only about 20% of cases are detected early enough for surgery. Consequently, most patients rely on chemotherapy, immunotherapy and radiotherapy. Among these, chemotherapy offers the best chance of tumor shrinkage, it comes with many problems such as harsh side effects which kill healthy cells and cancer cells, leaving the patient sometimes too ill to continue treatment. With immuno- and radiotherapy, it offers limited success in the treatment of pancreatic cancer despite its success in treating other forms of cancer. Nanotechnology offers promising opportunities for more effective diagnosis and less aggressive treatment. Fortunately, there has been some success for pancreatic cancer with two nano formulations currently approved by the Food and Drug Agency (Onivyde and Abraxane) offering greater survival rates and reduced side effects compared to traditional chemotherapy. Unfortunately, progress in nanotechnology-based diagnostics for pancreatic cancer remains limited. However, numerous different types of nanoparticles are under investigation in preclinical and clinical studies showing positive results. This review gives an overview of the potential of nanotechnology within this area looking at harnessing its potential in more effective diagnosis strategies and for more efficient therapy.\u003Cbr>Keywords: pancreatic cancer, drug delivery, cancer nanomedicine, diagnostics, theranostics, nanotechnology |\n| --- |\n| Introduction\u003Cbr>Pancreatic cancer (PC) is a highly fatal disease with 511,000 new cases and 467,000 deaths globally, in 2022 alone, ranking it as the 6th leading cause of cancer death and the 12th most prevalent cancer.1 PC has the worst 5-year survival rate compared to other common cancers, with only 12% of patients surviving, and as such in the UK, the cancer has been officially designated as a cancer ofunmet need. Unfortunately, giving the rising numbers of cases annually, the mortality to incidence ratio is expected to increase, with PC projected to become the second leading cause of cancer death by 2030 in the United States.1–3\u003Cbr>Pancreatic ductal adenocarcinoma (PDAC) is the most common form of exocrine PC and accounts for ~90% of all pancreatic malignancies.4 With ~60–70% of PDAC occurring at the head of the pancreas, 15% residing within the body and the remainder in the tail (15%) . Conventional treatment for PC includes surgery, chemo- and radiotherapy, with surgery being the most favourable option.5 However, due to a multitude of challenges such as the asymptomatic early stages, lack of known biomarkers resulting in lack of early detection/screening methods, PC is typically diagnosed at much later stages than the other cancers, with ~70–80% of cases being diagnosed at the locally advanced (LA) or metastatic stage.6–8 As a result, surgical resection is only feasible in fewer than 20% of patients, underscoring the urgent need for improved therapeutic and early diagnostic approaches.5 |\n\n[https://doi.org/10.2147/IJN.S559038](https://doi.org/10.2147/IJN.S559038)  \n[Received: 7 November 2025](Received: 7 November 2025)  \n[Accepted: 30 January 2026](Accepted: 30 Janua","cbCaikWVxYOqRVGz","https://ap.wps.com/l/cbCaikWVxYOqRVGz","pdf",4831735,"English","# Abstract\n# Introduction","[{\"question\":\"Why is pancreatic cancer difficult to diagnose early?\",\"answer\":\"Because clear early symptoms are absent, diagnosis is often delayed, leading many patients to present with advanced disease.\"},{\"question\":\"What treatment options are most commonly used for pancreatic cancer?\",\"answer\":\"Most patients rely on chemotherapy, immunotherapy, and radiotherapy, since only about 20% of cases are detected early enough for surgery.\"},{\"question\":\"How does nanotechnology aim to improve pancreatic cancer management?\",\"answer\":\"Nanotechnology supports more effective diagnosis and more efficient therapy, including nano-formulations that can offer improved survival rates and reduced side effects compared with traditional chemotherapy.\"}]","Developments - Potential of Nanotechnology for the Detection and Treatment of Pancreatic Cancer | PDF",1790056221,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b030d47b64197e298d321bdaad3c04aa.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc51c3d54ca8d6ee0c76b2c40c1eec47.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0126e9cb4f40d1ecb81ce2eb7c896971.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4372f32ff0ea14b239efec92de1a7062.webp",980,1268]